Literature DB >> 955006

Deficiency in renomedullary prostaglandin synthesis related to the evolution of essential hypertension.

N Papanicolaou, T Mountokalakis, M Safar, J Bariety, P Milliez.   

Abstract

Continued PG synthesis in the early stages of essential hypertension might reflect an activation of the renal antihypertensive function in respect to neurogenic and/or hormonal pression stimuli, subsequently a deficiency of renal PG synthesis related to irreversible changes with the kidney would lead to the prepoderance of a pressure mechanism, resulting to a further increase of blood pressure.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 955006     DOI： 10.1007/BF01933945

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  9 in total

1.  Nature and origin of the released prostaglandins following expansion of the blood volume.

Authors:  N Papanicoulaou
Journal:  J Pharm Pharmacol       Date:  1975-09       Impact factor: 3.765

Review 2.  Cardiovascular-renal effects of prostaglandins: the antihypertensive, natriuretic renal "endocrine" function.

Authors:  J B Lee
Journal:  Arch Intern Med       Date:  1974-01

3.  Prostaglandins in dog renal medulla.

Authors:  K Crowshaw; J C McGiff; J C Strand; A J Lonigro; N A Terrangno
Journal:  J Pharm Pharmacol       Date:  1970-04       Impact factor: 3.765

4.  Renal abnormality of essential hypertension.

Authors:  J J Brown; A F Lever; J I Robertson; M A Schalekamp
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

5.  Investigation on the mechanism of prostaglandins release.

Authors:  N Papanicolaou
Journal:  Experientia       Date:  1972-03-15

6.  Prostaglandins in rat tissues.

Authors:  N Papanicolaou; S Makrakis; J Bariety; P Milliez
Journal:  J Pharm Pharmacol       Date:  1974-04       Impact factor: 3.765

7.  Extraction of prostaglandins from human blood.

Authors:  W G Unger; I F Stamford; A Bennett
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

8.  The release of renal prostaglandins during saline infusion in normal and hypertensive subjects.

Authors:  N Papanicolaou; M Safar; A Hornych; F Fontaliran; Y Weiss; J Bariety; P Milliez
Journal:  Clin Sci Mol Med       Date:  1975-11

9.  Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity?

Authors:  P L Padfield; J J Brown; A F Lever; M A Schalekamp; D G Beevers; D L Davies; J I Robertson; M Tree
Journal:  Lancet       Date:  1975-03-08       Impact factor: 79.321
  9 in total
  3 in total

1.  Direct relationship between urinary prostaglandin E and sodium excretion in essential hypertensive patients.

Authors:  N Papanicolaou; N Lefkos; M Safar; M Paris; J Bariety; M Milliez
Journal:  Experientia       Date:  1976-10-15

Review 2.  Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective.

Authors:  P W de Leeuw
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

3.  Interaction between aldosterone and renomedullary prostaglandins. Competitive action between aspirin and spironolactone.

Authors:  N Papanicolaou; N Lefkos; E Massourides; S Marketos; J Papavassiliou; J Bariety; P Milliez
Journal:  Experientia       Date:  1977-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.